Moxibustion Alleviates Airway Inflammatory Response in Rats with Experimental Asthma by Increasing Short Chain Fatty Acids in Bone Marrow and Blood

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Treatment with moxibustion reduces airway inflammation in asthma models, suggesting SCFAs play a key role.

Moxibustion significantly decreases airway inflammation and immune response in asthmatic rats, leading to improved outcomes.
The BL13-ST25 treatment group showed notably lower levels of interleukins and immune cells compared to the model group.
Observational analysis using ELISA and gas chromatography-mass spectrometry demonstrated the effectiveness of moxibustion at regulating SCFAs.
These findings suggest moxibustion may offer a viable alternative for managing airway inflammation in asthma, warranting further investigation.

Zhou et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark